Using loss‐of‐function experiments, we demonstrated that the expression of two upstream enzymes of this metabolic pathway, HMGCS1 and HMGCR, is crucial for the primary tumorigenesis of breast cancer cells in vivo. The gene discussed is HMGCR; the disease is breast carcinoma.